The Research & Development to Sales ratio is a measure to compare the effectiveness of R&D expenditures between companies in the same industry. It is calculated as R&D expenditure divided by Total Sales. This is measured on a TTM basis.
This is calculated by dividing the Research & Development Expense by total sales or revenue.
R&D expense is not always broken out in a company's financials, however, so this value may be n/a in those cases.
Comparisons are not always useful across industries - for example, pharmaceuticals and software companies tend to spend a lot on R&D while consumer product companies spent less.
This is measured on a TTM basis.
| Ticker | Name | R&D / Sales | StockRank™ |
|---|---|---|---|
| LON:PRTC | Puretech Health | 17,525.00% | 5 |
| LON:ADT1 | Adriatic Metals | 1,695.02% | 2 |
| LON:GDR | Genedrive | 1,401.47% | 2 |
| LON:PHE | Powerhouse Energy | 752.31% | 19 |
| LON:4BB | 4Basebio | 697.63% | 22 |